Company: VCYT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001384101-25-000014
Chunk: 43

Company: VERACYTE, INC.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 43
---
3/2019

119

Table of Contents

Incorporated by ReferenceExhibit NumberDescriptionFormFile No.ExhibitFiling DateFiled Herewith10.8#Employment Agreement, dated as of May 7, 2021, between Marc Stapley and the Registrant10-Q001-3615610.27/29/202110.9#Change in Control and Severance Agreement, effective June 1, 2021 between Marc Stapley and the Registrant10-Q001-3615610.37/29/202110.10#Amended and Restated Offer Letter, dated August 15, 2021, between the Registrant and Rebecca Chambers10-Q001-3615610.111/9/202110.11#Change in Control and Severance Agreement, effective July 19, 2021 between Rebecca Chambers and the Registrant10-Q001-3615610.211/9/202110.12#Offer Letter, dated as of January 9, 2023, between Annie McGuire and the Registrant10-K001-3615610.323/1/202310.13#Change of Control and Severance Agreement, effective January 1, 2023, between Annie McGuire and the Registrant10-K001-3615610.333/1/202310.14#2023 Equity Incentive Plan, as amended8-K001-3615610.16/13/202410.15#Form of agreements under the 2023 Equity Incentive Plan8-K001-3615610.26/9/202310.16#Promotion Letter, dated as of August 22, 2023, between John Leite and the Registrant10-K001-3615610.232/29/202410.17#Change of Control and Severance Agreement, effective September 1, 2023, between John Leite and the Registrant10-K001-3615610.242/29/202410.18#Offer Letter, dated as of September 11, 2023, between Phil Febbo and the Registrant10-K001-3615610.252/29/202410.19#Change of Control and Severance Agreement, effective October 2, 2023, between Phil Febbo and the Registrant10-K001-3615610.262/29/202410.20#2019 Stock Incentive Plan of C2i Genomics